Informing patients that they are at high risk for serious complications of viral infection increases vaccination rates.

COVID-19 field experiments influenza machine learning algorithm nudges

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
23 Feb 2021
Historique:
pubmed: 4 3 2021
medline: 4 3 2021
entrez: 3 3 2021
Statut: epublish

Résumé

For many vaccine-preventable diseases like influenza, vaccination rates are lower than optimal to achieve community protection. Those at high risk for infection and serious complications are especially advised to be vaccinated to protect themselves. Using influenza as a model, we studied one method of increasing vaccine uptake: informing high-risk patients, identified by a machine learning model, about their risk status. Patients (N=39,717) were evenly randomized to (1) a control condition (exposure only to standard direct mail or patient portal vaccine promotion efforts) or to be told via direct mail, patient portal, and/or SMS that they were (2) at high risk for influenza and its complications if not vaccinated; (3) at high risk according to a review of their medical records; or (4) at high risk according to a computer algorithm analysis of their medical records. Patients in the three treatment conditions were 5.7% more likely to get vaccinated during the 112 days post-intervention (p < .001), and did so 1.4 days earlier (p < .001), on average, than those in the control group. There were no significant differences among risk messages, suggesting that patients are neither especially averse to nor uniquely appreciative of learning their records had been reviewed or that computer algorithms were involved. Similar approaches should be considered for COVID-19 vaccination campaigns.

Identifiants

pubmed: 33655258
doi: 10.1101/2021.02.20.21252015
pmc: PMC7924279
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIA NIH HHS
ID : P30 AG034532
Pays : United States

Déclaration de conflit d'intérêts

Competing Interest Statement: A.L. and R.Y. are employed by Medial EarlySign, which designs machine learning-based decision support and risk management tools for health systems. Medial EarlySign employees co-developed the algorithm used to risk-stratify participants but were not involved in the design of this study investigating the effects of disclosing risk status to patients or in the analysis of study data. D.M.W. received grants from Medial EarlySign to support her role in that prior work of co-developing and retrospectively validating the algorithm.

Auteurs

Maheen Shermohammed (M)

Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA.

Amir Goren (A)

Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA.

Alon Lanyado (A)

Medial EarlySign, Hod Hasharon, Israel.

Rachel Yesharim (R)

Medial EarlySign, Hod Hasharon, Israel.

Donna M Wolk (DM)

Department of Laboratory Medicine, Diagnostic Medicine Institute, Geisinger Health System, Danville, PA, USA.

Joseph Doyle (J)

Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA.
National Bureau of Economic Research, Cambridge, MA, USA.

Michelle N Meyer (MN)

Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA.
Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17822, USA.

Christopher F Chabris (CF)

Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA.
Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837, USA.

Classifications MeSH